Kevin H. Yang

451 total citations · 1 hit paper
22 papers, 235 citations indexed

About

Kevin H. Yang is a scholar working on Pharmacology, Clinical Psychology and Toxicology. According to data from OpenAlex, Kevin H. Yang has authored 22 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 10 papers in Clinical Psychology and 4 papers in Toxicology. Recurrent topics in Kevin H. Yang's work include Cannabis and Cannabinoid Research (11 papers), Psychedelics and Drug Studies (8 papers) and Forensic Toxicology and Drug Analysis (4 papers). Kevin H. Yang is often cited by papers focused on Cannabis and Cannabinoid Research (11 papers), Psychedelics and Drug Studies (8 papers) and Forensic Toxicology and Drug Analysis (4 papers). Kevin H. Yang collaborates with scholars based in United States, United Kingdom and Australia. Kevin H. Yang's co-authors include Benjamin H. Han, Joseph J. Palamar, Alison Moore, Stéphanie Knatz Peck, Walter H. Kaye, Christopher N. Kaufmann, Joel Castellanos, Matthew Lyes, Timothy Furnish and Michelle Sexton and has published in prestigious journals such as Nature Medicine, Pain and Journal of the American Geriatrics Society.

In The Last Decade

Kevin H. Yang

19 papers receiving 225 citations

Hit Papers

Psilocybin therapy for females with anorexia nervosa: a p... 2023 2026 2024 2025 2023 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study
    2023 73 citations Stéphanie Knatz Peck, Kevin H. Yang et al. Nature Medicine profile →

Peers

Kevin H. Yang
Dimitri Daldegan‐Bueno Brazil
Rayyan Zafar United Kingdom
Maha N. Mian United States
Cale Basaraba United States
Lucas Oliveira Maia Brazil
Lindsay A. Lo Canada
Kyle T. Greenway Canada
Udo Schneider Germany
Davide Arillotta Italy
Imre Bárd United Kingdom
Dimitri Daldegan‐Bueno Brazil
Kevin H. Yang
Citations per year, relative to Kevin H. Yang Kevin H. Yang (= 1×) peers Dimitri Daldegan‐Bueno

Countries citing papers authored by Kevin H. Yang

Since Specialization
Citations

This map shows the geographic impact of Kevin H. Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin H. Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin H. Yang more than expected).

Fields of papers citing papers by Kevin H. Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin H. Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin H. Yang. The network helps show where Kevin H. Yang may publish in the future.

Co-authorship network of co-authors of Kevin H. Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin H. Yang. A scholar is included among the top collaborators of Kevin H. Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin H. Yang. Kevin H. Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Kevin H., et al.. (2025). Saliva detection of the cannabinoids tetrahydrocannabinolic acid A (THCA-A) and cannabinol (CBN) among nightclub attendees in New York City, 2024. The American Journal of Drug and Alcohol Abuse. 51(4). 484–491. 1 indexed citations
3.
Yang, Kevin H., et al.. (2025). U.S. State Marijuana and Delta-8-Tetrahydrocannabinol Laws and Delta-8-Tetrahydrocannabinol Use. American Journal of Preventive Medicine. 69(6). 108026–108026. 1 indexed citations
4.
5.
6.
Urban, Christian, Kevin H. Yang, & Joseph J. Palamar. (2025). Nicotine and cannabis vaping-related workplace absenteeism among U.S. Adults, 2022. Addictive Behaviors. 167. 108362–108362. 1 indexed citations
7.
Yang, Kevin H., et al.. (2024). Cannabis Use, Use Disorder, and Workplace Absenteeism in the U.S., 2021–2022. American Journal of Preventive Medicine. 67(6). 803–810. 3 indexed citations
8.
Leas, Eric C., et al.. (2024). Need for a Public Health Response to the Unregulated Sales of Amanita muscaria Mushrooms. American Journal of Preventive Medicine. 67(3). 458–463. 4 indexed citations
9.
Peck, Stéphanie Knatz, et al.. (2024). Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility Study. FOCUS The Journal of Lifelong Learning in Psychiatry. 22(3). 381–387.
10.
Yang, Kevin H., et al.. (2024). Trends and characteristics in ketamine use among US adults with and without depression, 2015–2022. Journal of Affective Disorders. 373. 345–352. 5 indexed citations
11.
Peck, Stéphanie Knatz, et al.. (2023). Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study. Nature Medicine. 29(8). 1947–1953. 73 indexed citations breakdown →
12.
Yang, Kevin H., et al.. (2023). Prevalence and Correlates of Past Year Ecstasy/MDMA Use in the United States. Journal of Addiction Medicine. 17(5). 592–597. 5 indexed citations
13.
Yang, Kevin H., et al.. (2023). Trends in past-month cannabis use among US adults across a range of disabilities and health conditions, 2015–2019. Preventive Medicine. 177. 107768–107768. 4 indexed citations
14.
Yang, Kevin H., Benjamin H. Han, & Joseph J. Palamar. (2022). Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults. Addictive Behaviors. 132. 107343–107343. 16 indexed citations
15.
Yang, Kevin H., et al.. (2022). Case report: Rare lung disease of infancy diagnosed with the assistance of a home pulse oximetry baby monitor. Frontiers in Pediatrics. 10. 918764–918764. 1 indexed citations
16.
Kaufmann, Christopher N., Atul Malhotra, Kevin H. Yang, et al.. (2022). Cannabis use for Sleep Disturbance Among Older Patients in a Geriatrics Clinic. The International Journal of Aging and Human Development. 97(1). 3–17. 4 indexed citations
17.
Yang, Kevin H., Benjamin H. Han, Alison Moore, & Joseph J. Palamar. (2022). Trends in major depressive episodes and mental health treatment among older adults in the United States, 2010–2019. Journal of Affective Disorders. 318. 299–303. 12 indexed citations
18.
Lyes, Matthew, Kevin H. Yang, Joel Castellanos, & Timothy Furnish. (2022). Microdosing psilocybin for chronic pain: a case series. Pain. 164(4). 698–702. 33 indexed citations
19.
Yang, Kevin H., et al.. (2020). CANNABIS USE FOR ANXIETY AMONG OLDER ADULTS. American Journal of Geriatric Psychiatry. 28(4). S81–S82. 2 indexed citations
20.
Yang, Kevin H., Christopher N. Kaufmann, Ella T. Lifset, et al.. (2020). Cannabis: An Emerging Treatment for Common Symptoms in Older Adults. Journal of the American Geriatrics Society. 69(1). 91–97. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitri Daldegan‐Bueno Breakdown of academic impact, for papers by Rayyan Zafar Breakdown of academic impact, for papers by Maha N. Mian Breakdown of academic impact, for papers by Cale Basaraba Breakdown of academic impact, for papers by Lucas Oliveira Maia Breakdown of academic impact, for papers by Lindsay A. Lo Breakdown of academic impact, for papers by Kyle T. Greenway Breakdown of academic impact, for papers by Udo Schneider Breakdown of academic impact, for papers by Davide Arillotta Breakdown of academic impact, for papers by Imre Bárd
Rankless by CCL
2026